CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare liver disease: phase 3 trial launches
Disease control Recruiting nowThis study tests a new drug called libevitug in 160 people with chronic hepatitis D, a serious liver infection. Participants receive the drug intravenously every two weeks for up to 96 weeks. The goal is to see if the drug can lower the virus level and improve liver health.
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 26, 2026 07:13 UTC
-
New hope for rare liver virus: phase 3 trial launches
Disease control Recruiting nowThis study tests a new drug, BJT-778, against an existing one (bulevirtide) for chronic hepatitis delta, a serious liver infection. About 172 adults with the virus will receive either drug to see which better controls the virus and normalizes liver enzymes. Participants must alre…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New drug shows promise in battle against rare liver infection
Disease control Recruiting nowThis study tests a new medicine called brelovitug for people with chronic hepatitis delta, a serious liver infection. About 80 adults will either get brelovitug right away or wait a bit before starting treatment. The goal is to see if the drug can lower the virus level and improv…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC